Literature DB >> 8787673

Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.

H H Lemmink1, W N Nillesen, T Mochizuki, C H Schröder, H G Brunner, B A van Oost, L A Monnens, H J Smeets.   

Abstract

Benign familial hematuria (BFH) is characterized by autosomal dominant inheritance, thinning of the glomerular basement membrane (GBM) and normal renal function. It is frequent in patients with persistent microscopic hematuria, but cannot be clinically differentiated from the initial stages of Alport syndrome, a severe GBM disorder which progresses to renal failure. We present here linkage of benign familial hematuria with the COL4A3 and COL4A4 genes at 2q35-37 (Zmax = 3.58 at theta = 0.0). Subsequently, a glycine to glutamic acid substitution was identified in the collagenous region of the COL4A4 gene. We conclude that type IV collagen defects cause both benign hematuria and Alport syndrome. Furthermore, our data suggest that BFH patients can be carriers of autosomal recessive Alport syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787673      PMCID: PMC507532          DOI: 10.1172/JCI118893

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Alport's syndrome. Emphasizing electron microscopic studies of the glomerulus.

Authors:  G S Spear; R J Slusser
Journal:  Am J Pathol       Date:  1972-11       Impact factor: 4.307

4.  Quantitative estimation of cells in urine. An evaluation of the Addis count.

Authors:  H Gadeholt
Journal:  Acta Med Scand       Date:  1968-04

5.  Split and extremely thin glomerular basement membranes in hereditary nephropathy (Alport's syndrome).

Authors:  H J Rumpelt; K H Langer; K Schärer; E Straub; W Thoenes
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

6.  Hereditary nephropathy (Alport syndrome): correlation of clinical data with glomerular basement membrane alterations.

Authors:  H J Rumpelt
Journal:  Clin Nephrol       Date:  1980-05       Impact factor: 0.975

7.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

8.  Glomerular basement membrane attenuation in familial nephritis and "benign" hematuria.

Authors:  C F Piel; C G Biava; J R Goodman
Journal:  J Pediatr       Date:  1982-09       Impact factor: 4.406

9.  Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.

Authors:  T Mochizuki; H H Lemmink; M Mariyama; C Antignac; M C Gubler; Y Pirson; C Verellen-Dumoulin; B Chan; C H Schröder; H J Smeets
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

10.  Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome.

Authors:  H H Lemmink; T Mochizuki; L P van den Heuvel; C H Schröder; A Barrientos; L A Monnens; B A van Oost; H G Brunner; S T Reeders; H J Smeets
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

View more
  32 in total

1.  Haematuria in asymptomatic individuals.

Authors:  J Savige; M Buzza; H Dagher
Journal:  BMJ       Date:  2001-04-21

2.  ALPORTS NEPHRITIS: A Report of Two Cases.

Authors:  N S Mani; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  COL4A4 gene study of a European population: description of new mutations causing autosomal dominant Alport syndrome.

Authors:  Consolación Rosado; Elena Bueno; Carmen Felipe; Rogelio González-Sarmiento
Journal:  Int J Mol Epidemiol Genet       Date:  2014-12-15

Review 4.  The triple helix of collagens - an ancient protein structure that enabled animal multicellularity and tissue evolution.

Authors:  Aaron L Fidler; Sergei P Boudko; Antonis Rokas; Billy G Hudson
Journal:  J Cell Sci       Date:  2018-04-09       Impact factor: 5.285

Review 5.  Familial hematurias: what we know and what we don't.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

6.  Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome.

Authors:  E Boye; G Mollet; L Forestier; L Cohen-Solal; L Heidet; P Cochat; J P Grünfeld; J B Palcoux; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

7.  A family with X-linked benign familial hematuria.

Authors:  Kazunari Kaneko; Sachiyo Tanaka; Masafumi Hasui; Kandai Nozu; Rafal Przybyslaw Krol; Kazumoto Iijima; Keisuke Sugimoto; Tsukasa Takemura
Journal:  Pediatr Nephrol       Date:  2010-03       Impact factor: 3.714

8.  Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.

Authors:  Stefanie Weber; Katja Strasser; Sabine Rath; Achim Kittke; Sonja Beicht; Martin Alberer; Bärbel Lange-Sperandio; Peter F Hoyer; Marcus R Benz; Sabine Ponsel; Lutz T Weber; Hanns-Georg Klein; Julia Hoefele
Journal:  Pediatr Nephrol       Date:  2016-01-25       Impact factor: 3.714

Review 9.  The expanding phenotypic spectra of kidney diseases: insights from genetic studies.

Authors:  Marijn F Stokman; Kirsten Y Renkema; Rachel H Giles; Franz Schaefer; Nine V A M Knoers; Albertien M van Eerde
Journal:  Nat Rev Nephrol       Date:  2016-07-04       Impact factor: 28.314

10.  The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy.

Authors:  Stephen Tonna; Yan Yan Wang; Diane Wilson; Lin Rigby; Tania Tabone; Richard Cotton; Judy Savige
Journal:  Pediatr Nephrol       Date:  2008-08-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.